Search results for "obstructive sleep apnea."

showing 10 items of 152 documents

Abnormal thyroid hormones and non-thyroidal illness syndrome in obstructive sleep apnea, and effects of CPAP treatment

2016

Objective In obstructive sleep apnea (OSA), while both hypothyroidism and hyperthyroidism have been studied, the occurrence of non-thyroidal illness syndrome (NTIS) (normal thyroid stimulating hormone [TSH] with low triiodotironine) has not been investigated. We explored the occurrence of NTIS in patients with moderate to severe OSA and its relationship to the severity of nocturnal respiratory disorders. We also studied the occurrence of subclinical hypothyroidism (SH, ie, high TSH with normal thyroxine) in OSA and changes in circulating TSH, free triiodotironine (fT3) and free thyroxine (fT4) after CPAP treatment. Methods After a nocturnal respiratory polysomnography, 125 consecutive patie…

Maleendocrine system diseasesSettore MED/10 - MALATTIE DELL'APPARATO RESPIRATORIOPolysomnographyGastroenterologyHypoxemiaHypoxemia0302 clinical medicineSubclinical hypothyroidismThyroid stimulating hormoneobstructive sleep apneaOxygen saturation (medicine)Subclinical infectionSleep Apnea ObstructiveContinuous Positive Airway Pressuremedicine.diagnostic_testMedicine (all)apnee ostruttive nel sonnoGeneral MedicineMiddle Agedfunzione tiroideaTriiodothyronineFemalemedicine.symptomhormones hormone substitutes and hormone antagonistsThyroid Hormonesendocrine systemmedicine.medical_specialtyPolysomnography03 medical and health sciencesThyroid-stimulating hormoneInternal medicinemedicineHumansthyroid functionbusiness.industrymedicine.diseaseEuthyroid Sick Syndromesrespiratory tract diseasesThyroid hormoneObstructive sleep apneaThyroxineEndocrinology030228 respiratory systemCase-Control Studiesbusiness030217 neurology & neurosurgeryEuthyroid sick syndromeHormoneEuthyroid sick syndromeSleep Medicine
researchProduct

Metabolic Syndrome in Patients with Coexistent Obstructive Sleep Apnea Syndrome and Chronic Obstructive Pulmonary Disease (Overlap Syndrome).

2020

Background: Evidence suggests that metabolic syndrome (MetS) is highly prevalent in patients with obstructive sleep apnea syndrome (OSAS) and chronic obstructive pulmonary disease (COPD). However, ...

Malemedicine.medical_specialtyEndocrinology Diabetes and MetabolismPulmonary disease030209 endocrinology & metabolismComorbidity030204 cardiovascular system & hematologyurologic and male genital diseasesRisk Assessment03 medical and health sciencesPulmonary Disease Chronic Obstructive0302 clinical medicineRisk FactorsInternal medicineInternal MedicinemedicinePrevalenceHumansIn patientAgedMetabolic SyndromeCOPDSleep Apnea ObstructiveGreecebusiness.industryOverlap syndromeMiddle Agedmedicine.diseaseObesityrespiratory tract diseasesObstructive sleep apneaCross-Sectional StudiesCardiologyFemaleMetabolic syndromebusinessMetabolic syndrome and related disorders
researchProduct

Gelatinases and their tissue inhibitors in a group of subjects with obstructive sleep apnea syndrome.

2016

Obstructive sleep apnea syndrome (OSAS) is associated with an elevated risk of cardiovascular events and stroke. Matrix metalloproteinases (MMPs) are endopeptidases involved in extracellular matrix degradation and then in the development and progression of cardiovascular diseases. Our aim was to evaluate plasma levels of gelatinases (MMP-2 and MMP-9) and their tissue inhibitors (TIMP-1 and TIMP-2) in a group of subjects with OSAS. We enrolled 48 subjects (36 men and 12 women; mean age 49.7 ± 14.68 yrs) with OSAS diagnosed with a 1-night cardiorespiratory study and then we subdivided these subjects into two subgroups according to the apnea/hypopnea index (AHI): Low (L = 21 subjects with AHI …

Malemedicine.medical_specialtyGelatinasesSettore MED/09 - Medicina InternaPhysiologyMMP-2; MMP-9; obstructive sleep apnea; TIMP-1; TIMP-2; Disease Progression; Female; Gelatinases; Humans; Male; Middle Aged; Sleep Apnea Obstructive; Tissue Inhibitor of Metalloproteinase-1; Physiology; Hematology; Cardiology and Cardiovascular Medicine; Physiology (medical)030204 cardiovascular system & hematologyMatrix metalloproteinaseGastroenterologyTIMP-203 medical and health sciencesTIMP-10302 clinical medicinePhysiology (medical)Internal medicinemedicineHumansStrokeobstructive sleep apneaOxygen saturation (medicine)Sleep Apnea ObstructiveTissue Inhibitor of Metalloproteinase-1MMP-2business.industryApneaCardiorespiratory fitnessHematologyMiddle Agedmedicine.diseasenervous system diseasesrespiratory tract diseasesObstructive sleep apneaEndocrinology030228 respiratory systemGelatinaseGelatinasesDisease ProgressionFemalemedicine.symptomMMP-9Settore MED/36 - Diagnostica Per Immagini E RadioterapiaCardiology and Cardiovascular MedicinebusinessHypopneaHumanClinical hemorheology and microcirculation
researchProduct

Lipid peroxidation and nitric oxide metabolites in a group of subjects with obstructive sleep apnea syndrome.

2015

It is known that in OSAS the plasma lipid peroxidation has an opposite behavior in comparison with nitric oxide metabolites. In the re-examination of our survey of OSAS subjects we calculated the ratio between thiobarbituric acid reactive substances (TBARS) and nitric oxide metabolites (NOx) in relation to OSAS severity. The study has regarded 48 OSAS subjects subdivided in two subgroups according to the apnea/hypopnea index - AHI- (Low = 21 subjects with AHI30 and High = 27 subjects with AHI30). From the obtained data it is evident that the TBARS/NOx ratio is significantly higher in the H subgroup compared to L subgroup as well as this ratio is reduced in L subgroup in comparison with the …

Malemedicine.medical_specialtyPhysiologyThiobarbituric acidobstructive sleep apnea syndrome030204 cardiovascular system & hematologyNitric OxideNitric oxideLipid peroxidation03 medical and health scienceschemistry.chemical_compound0302 clinical medicinestomatognathic systemnitric oxide metabolitePhysiology (medical)Internal medicineTBARSLipid peroxidation; nitric oxide metabolites; obstructive sleep apnea syndrome; Female; Humans; Lipid Peroxidation; Male; Middle Aged; Nitric Oxide; Sleep Apnea Obstructive; Physiology; Hematology; Cardiology and Cardiovascular Medicine; Physiology (medical)MedicineHumansNOxSleep Apnea Obstructivebusiness.industryApneaHematologyMiddle Agedmedicine.diseasenervous system diseasesrespiratory tract diseasesObstructive sleep apneaEndocrinology030228 respiratory systemchemistryFemaleLipid Peroxidationmedicine.symptomCardiology and Cardiovascular MedicinebusinessHypopneaHumanClinical hemorheology and microcirculation
researchProduct

Metabolic Syndrome and Vitamin D Levels in Patients with Obstructive Sleep Apnea Syndrome

2018

Numerous studies have indicated that obstructive sleep apnea syndrome (OSAS), may contribute to the development of metabolic syndrome (MetS) and diabetes. Moreover, OSAS has been associated with lowered vitamin D (Vit D) levels, but reports are inconclusive. Aim of the study was to compare Vit D levels according to the presence of MetS and its components in OSAS patients.The presence of MetS was evaluated and serum 25-hydroxy vitamin D [25(OH)D] levels were measured in consecutive newly diagnosed, by polysomnography, subjects with OSAS.A total of 107 subjects (88 men) with OSAS were included in the study. Patients were divided into group A (OSAS with MetS group: 55 subjects) and group B (OS…

Malemedicine.medical_specialtyPolysomnographyEndocrinology Diabetes and MetabolismBlood Pressure030209 endocrinology & metabolismPolysomnographySeverity of Illness IndexGastroenterologyGroup BBody Mass Index03 medical and health sciences0302 clinical medicineDiabetes mellitusInternal medicineInternal MedicineVitamin D and neurologyHumansMedicineVitamin DAgedMetabolic SyndromeSleep Apnea ObstructiveAnthropometrymedicine.diagnostic_testbusiness.industryEpworth Sleepiness ScaleVitaminsMiddle AgedVitamin D Deficiencymedicine.diseasenervous system diseasesrespiratory tract diseasesObstructive sleep apneaFemaleMetabolic syndromebusinessBody mass index030217 neurology & neurosurgeryMetabolic Syndrome and Related Disorders
researchProduct

Efficacy of mandibular advancement device in the treatment of obstructive sleep apnea syndrome: A randomized controlled crossover clinical trial

2015

Background Evaluation of the efficacy and safety of a mandibular advancement device (MAD) (KlearwayTM) in the treatment of mild-to-moderate obstructive sleep apnea and chronic roncopathy. Material and Methods A randomized, placebo-controlled, double blinded, and crossover clinical trial was conducted. Placebo device (PD) defined as a splint in the centric occlusion that did not induce a mandibular advancement served as a control. The mandible was advanced to the maximum tolerable distance or to a minimum of 65% of the maximum protrusion. After each sequence of treatment, patients were assessed by questionnaires, conventional polysomnography, and objective measurement of snoring at the patie…

Malemedicine.medical_specialtyanimal structuresOdontologíaPolysomnographyPlaceboSeverity of Illness Indexlaw.inventionRandomized controlled trialstomatognathic systemDouble-Blind MethodlawSeverity of illnessmedicineHumansGeneral DentistrySleep Apnea ObstructiveCross-Over Studiesmedicine.diagnostic_testbusiness.industryResearchSleep apneaMiddle Agedmedicine.disease:CIENCIAS MÉDICAS [UNESCO]Medically compromised patients in DentistryCrossover studyCiencias de la saludSurgeryrespiratory tract diseasesClinical trialObstructive sleep apneaTreatment OutcomeOtorhinolaryngologyAnesthesiaUNESCO::CIENCIAS MÉDICASSurgeryFemalebusinessMandibular AdvancementMedicina Oral, Patología Oral y Cirugía Bucal
researchProduct

Cancer prevalence is increased in females with sleep apnoea: data from the ESADA study

2019

[No abstract available]

MaleobesityLetterDatabases FactualDownload[SDV]Life Sciences [q-bio]cigarette smokingPolysomnographycancer riskdisease burdenapnea hypopnea indexsleep disordered breathingstudy design0302 clinical medicinepolysomnographyRisk FactorsNothingcancer diagnosisNeoplasmsmiddle agedgenderPrevalence030212 general & internal medicineSleep studyobstructive sleep apneaSleep Apnea Obstructiveeducation.field_of_studyanthropometryquantitative analysismedicine.diagnostic_testadultrisk assessmentclinical trialcohort analysisprostate cancerpulse oximetry[SDV] Life Sciences [q-bio]Europenot availablecomorbidityagedfemalewaist hip ratiocolon cancerpriority journalrisk factorfactual databasedisease severitycerebrovascular accidentPulmonary and Respiratory Medicinemedicine.medical_specialtyalcohol consumptionintermittent hypoxiaPopulationMEDLINElymphomaSettore MED/10 - Malattie Dell'Apparato Respiratoriomalignant neoplasmcancer growth03 medical and health sciencesmelanomamedicinecancercross-sectional studyHumanscontrolled studyhumaneducationCancer prevalencehypoxiabusiness.industrystatistical modelConflict of interestpredictionmajor clinical studybody massoxygen saturationlung cancermulticenter studyCross-Sectional StudiesLogistic Modelsage030228 respiratory systemdisease severity assessmentFamily medicineoxygen desaturation indexhead and neck cancerHuman medicinebusinessneoplasmEuropean Respiratory Journal
researchProduct

Perioperative Adverse Events in Obstructive Sleep Apnea and Use of Noninvasive Mechanical Ventilation: Key Topics and Clinical Implications

2016

Obstructive sleep apnea (OSA) is a common public health care problem and, yet, the perioperative management of OSA remains inadequate. Patients affected by this condition are prone to early postoperative complications, in part due to the negative effects of sedative, analgesic, and anesthetic agents on pharyngeal tone and arousal responses to hypoxia, hypercapnia, and obstruction. The use of opioids may also contribute to late adverse events, mainly by suppressing the rapid eye movement phase of sleep. As a result, preoperative screening of patients at high risk of OSA, as well as the implementation of a perioperative strategy to reduce the risk of complications, should lead to early periop…

Mechanical ventilationmedicine.medical_specialtymedicine.drug_classbusiness.industrymedicine.medical_treatmentPerioperativeHypoxia (medical)medicine.diseaserespiratory tract diseasesObstructive sleep apneaSedativeObstructive sleep apnea Perioperative complications Noninvasive ventilation Noninvasive positive pressure ventilation Continuous positive airway pressuremedicineContinuous positive airway pressuremedicine.symptomIntensive care medicineAdverse effectbusinessHypercapnia
researchProduct

The Role of Modified Expansion Sphincter Pharyngoplasty in Multilevel Obstructive Sleep Apnea Syndrome Surgery

2017

Introduction Obstructive sleep apnea syndrome (OSAS) is a sleep disorder caused by an excessive narrowing of the pharyngeal airway that also collapses during inspiration, with an important role played by the lateral pharyngeal wall in the development of the obstruction. Objective To describe our surgical experience with modified expansion sphincter pharyngoplasty (MESP) in the management of lateral collapse in upper airway multilevel surgery. Methods A total of 20 patients with moderate to severe OSAS were recruited in the Ear, Nose and Throat (ENT) Department of the University of Palermo, Italy. All of the enrolled patients refused the ventilatory therapy. The subjects were evaluated for …

Müller's maneuvermedicine.medical_specialtymedicine.medical_treatmentlcsh:Medicineobstructive sleep apnea syndromenasopharyngeal disease03 medical and health sciences0302 clinical medicinemedicinesleep apnea syndromesnasopharyngeal diseasessleep apnea syndrome030223 otorhinolaryngologyNoseOriginal ResearchSleep disordersoft palateobstructive sleep apnea hypopnea syndromeSoft palatebusiness.industryOtorhinolaryngology2734 Pathology and Forensic Medicinesleep-disordered breathinglcsh:RSleep apnea030206 dentistrymedicine.diseaselcsh:Otorhinolaryngologylcsh:RF1-547Surgeryrespiratory tract diseasesObstructive sleep apneamedicine.anatomical_structureOtorhinolaryngologySphincterAirwaybusinessInternational Archives of Otorhinolaryngology
researchProduct

Fusion of the

2015

Chronic obstructive pulmonary disease, COPD, affects the condition of the entire human organism and causes multiple comorbidities. Pathological lung changes lead to quantitative changes in the composition of the metabolites in different body fluids. The obstructive sleep apnea syndrome, OSAS, occurs in conjunction with chronic obstructive pulmonary disease in about 10–20 % of individuals who have COPD. Both conditions share the same comorbidities and this makes differentiating them difficult. The aim of this study was to investigate whether it is possible to diagnose a patient with either COPD or the OSA syndrome using a set of selected metabolites and to determine whether the metabolites t…

NMR spectroscopyOriginal ArticleChronic obstructive pulmonary disease (COPD)ChemometricsObstructive sleep apnea syndrome (OSAS)Discriminant modelsrespiratory tract diseasesMetabolomics : Official journal of the Metabolomic Society
researchProduct